Patients Tell FDA They Need Access to Cancer Drugs

Patients and advocacy groups told a Food and Drug Administration (FDA) advisory panel on Thursday that there is not enough access to potentially life-saving cancer therapies that are still considered experimental. The FDA asked its Oncologic Drugs Advisory Committee to consider whether changes are needed to the agency’s policy on giving severely ill patients special…